|
31 |
A Systematic Review and Critical Assessment of Health State Utilities
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 12, date:12.2012: 1133-1143
|
|
|
|
32 |
A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis
Enthalten in PharmacoEconomics Bd. 30, 30.12.2012, Nr. 1, date:1.2012: 63-80
|
|
|
|
33 |
Abiraterone Acetate
Enthalten in Drugs in R & D Bd. 10, 25.11.2012, Nr. 4, date:11.2010: 261-269
|
|
|
|
34 |
Abiraterone Acetate: A Guide to Its Use in Metastatic Castration-Resistant Prostate Cancer
Enthalten in Drugs & aging Bd. 29, 11.9.2012, Nr. 3, date:3.2012: 243-248
|
|
|
|
35 |
Access with Evidence Development
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 2, date:2.2010: 153-162
|
|
|
|
36 |
Access with Evidence Development in the UK
Enthalten in PharmacoEconomics Bd. 28, 23.9.2012, Nr. 2, date:2.2010: 163-170
|
|
|
|
37 |
Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder
Enthalten in CNS drugs Bd. 25, 29.8.2012, Nr. 1, date:1.2011: 17-36
|
|
|
|
38 |
Acknowledgement
Enthalten in PharmacoEconomics Bd. 30, 23.12.2012, Nr. 12, date:12.2012: 1097-1099
|
|
|
|
39 |
Acknowledgement
Enthalten in Clinical drug investigation Bd. 30, 24.8.2012, Nr. 12, date:12.2010: 805-810
|
|
|
|
40 |
Acknowledgement
Enthalten in Sports medicine Bd. 39, 1.12.2009, Nr. 12, date:12.2009: 977-979
|
|
Administration
